Article
Informed consent
Harrow launches partnership with mail-order pharmacy, PhilRx to expand access to VEVYE
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Stealth BioTherapeutics reaches 50 percent enrollment target in phase 3 ReNEW study
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Case report: Bilateral retinal detachments in a 19-year-old
ARVO announces recipients of the 2025 ARVO Foundation Early Career Clinician-Scientist Awards
